General Infectious Disease News Articles

Infectious Dis.

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jaksch P et al. - A 12-month CMV prophylaxis with oral valganciclovir is effective in significantly reducing CMV viremia and CMV disease/syndrome in high-risk lung transplant recipients. In addition, a reduction in acute and recurrent rejection episodes was observed, possibly due to less CMV viremia and subsequent immunomodulatory effects.

Related Articles

Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/02/09    Relevance Score: 84%

Today in Antimicrobials...keeping you current

Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals
Canadian Journal of Infectious Diseases, 12/15/09

Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid
International Journal of Infectious Diseases, 12/15/09

The efficacy of Echinacea in a 3-D tissue model of human airway epithelium
Phytotherapy Research, 12/15/09